DMIIU (NASDAQ:DMIIU – Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 76 shares, a decline of 34.5% from the September 30th total of 116 shares. Based on an average daily trading volume, of 1,039 shares, the short-interest ratio is currently 0.1 days.
DMIIU Price Performance
Shares of DMIIU stock opened at $10.27 on Wednesday. DMIIU has a 1-year low of $9.97 and a 1-year high of $10.80. The stock has a 50-day moving average of $10.24 and a 200-day moving average of $10.14.
DMIIU Company Profile
Drugs Made In America Acquisition II Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses, which we refer to throughout this prospectus as our “initial business combination.” To date, our efforts have been limited to organizational activities as well as activities related to this offering.
Featured Articles
- Five stocks we like better than DMIIU
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for DMIIU Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DMIIU and related companies with MarketBeat.com's FREE daily email newsletter.
